312325-72-7

Basic information

• Product Name: 2-(5-bromopyridin-2-yl)acetonitrile
• Synonyms: 2-(5-bromopyridin-2-yl)acetonitrile;5-Bromo-2-cyanomethylpyridine;5-BroMopyridine-2-acetoni...;2-(5-broMo-2-pyridyl)acetonitrile;5-BroMopyridine-2-acetonitrile;2-Pyridineacetonitrile, 5-bromo-
• CAS NO: 312325-72-7
• Molecular Formula: C7H5BrN2
• Molecular Weight: 197.035
• Product Categories: cyanide| alkyl bromide
• Mol File: 312325-72-7.mol
• Article Data: 10

Chemical Properties

• Melting Point: 29 °C
• Boiling Point: 285.4°C at 760 mmHg
• Flash Point: 126.4°C
• Appearance: /
• Density: 1.575g/cm³
• Vapor Pressure: 0.00281mmHg at 25°C
• Refractive Index: 1.578
• Storage Temp.: Room temperature.
• PKA: 0.82±0.22(Predicted)
• CAS DataBase Reference: 2-(5-bromopyridin-2-yl)acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-bromopyridin-2-yl)acetonitrile(312325-72-7)
• EPA Substance Registry System: 2-(5-bromopyridin-2-yl)acetonitrile(312325-72-7)

Safety Data

• Hazardous Substances Data: 312325-72-7(Hazardous Substances Data)

Usage

General Description

2-(5-bromopyridin-2-yl)acetonitrile is a chemical compound with the molecular formula C7H5BrN2. It is a white to off-white solid that is soluble in organic solvents. 2-(5-bromopyridin-2-yl)acetonitrile is commonly used in organic synthesis and can act as a versatile building block in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It is also used as an intermediate in the synthesis of various biologically active molecules and can be utilized in the development of new materials. Additionally, 2-(5-bromopyridin-2-yl)acetonitrile may also have potential applications in the fields of medicinal chemistry and drug discovery.

InChI:InChI=1/C7H5BrN2/c8-6-1-2-7(3-4-9)10-5-6/h1-2,5H,3H2

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 75-05-8 acetonitrile 
• 831203-34-0 tert-butyl (5-bromo-2(1H)-pyridinylidene)cyanoacetate 
• 168823-76-5 5-bromo-2-(chloromethyl)pyridine 
• 145218-19-5 5-bromo-2-(bromomethyl)pyridine 
• 3430-13-5 5-bromo-2-methylpyridine 
• 7677-24-9 trimethylsilyl cyanide 
• 766-11-0 5-bromo-2-fluoropyridine 

Downstream Products

• 827628-15-9 1-(5-bromopyridin-2-yl)cyclopropane-1-carbonitrile 
• 827628-42-2 1-(5-bromopyridin-2-yl)cyclopropanecarboxylic acid 
• 917023-06-4 methyl 2-(5-bromopyridin-2-yl)acetate 
• 1428761-14-1 methyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate 
• 1582261-90-2 2,2-dichloro-N-((1R,2S)-1-(4-(6-(cyanomethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)acetamide 

Relevant articles and documents

PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS

The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them highly advantageous for use in therapy, particularly in the treatment or prevention of cancer, a neovascular eye disease, inflammatory pain, or an inflammatory disease, such as, e.g., multiple sclerosis, rheumatoid arthritis or endometriosis.

Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)

The discovery of potent, peptide site directed, tyrosine kinase inhibitors has remained an elusive goal. Herein we describe the discovery of two such clinical candidates that inhibit the tyrosine kinase Src. Compound 1 is a phase 3 clinical trial candidat

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.